Cannabidiol
- Generic Name
- Cannabidiol
- Brand Names
- Epidiolex, Sativex, Epidyolex
- Drug Type
- Small Molecule
- Chemical Formula
- C21H30O2
- CAS Number
- 13956-29-1
- Unique Ingredient Identifier
- 19GBJ60SN5
- Background
Cannabidiol, or CBD, is one of at least 85 active cannabinoids identified within the Cannabis plant. It is a major phytocannabinoid, accounting for up to 40% of the Cannabis plant's extract, that binds to a wide variety of physiological targets of the endocannabinoid system within the body. Although the exact medical implications are currently being investig...
- Indication
When used in combination with delta-9-tetrahydrocannabinol as the product Sativex, cannabidiol was given a standard marketing authorization (ie. a Notice of Compliance (NOC)) by Health Canada for the following indications:
...
- Associated Conditions
- Multiple Sclerosis, Seizures, Severe Pain, Moderate Pain
- Associated Therapies
- -
CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis.
- Conditions
- Interventions
- First Posted Date
- 2018-10-03
- Last Posted Date
- 2021-07-07
- Lead Sponsor
- Aalborg University Hospital
- Target Recruit Count
- 136
- Registration Number
- NCT03693833
- Locations
- 🇩🇰
Department of Rheumatology Aalborg Universityhospital North, Aalborg, Denmark
Cannabidiol for Drug Resistant Pediatric Epilepsy (Expanded Access Use)
- Conditions
- Locations
- 🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
Cannabis Oil for Chronic Non-Cancer Pain Treatment
- First Posted Date
- 2018-08-17
- Last Posted Date
- 2018-11-13
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 309
- Registration Number
- NCT03635593
- Locations
- 🇨🇦
Michael G. DeGroote Pain Clinic, Hamilton, Ontario, Canada
🇨🇦Toronto Poly Clinic, Toronto, Ontario, Canada
Cannabidiol in Patients With Heart Failure Failure in AHA/ACC Stages A-C
- First Posted Date
- 2018-08-16
- Last Posted Date
- 2020-08-05
- Target Recruit Count
- 20
- Registration Number
- NCT03634189
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
- First Posted Date
- 2018-07-31
- Last Posted Date
- 2018-07-31
- Lead Sponsor
- Leaf Vertical Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT03607643
- Locations
- 🇺🇸
Southwest Cancer Center, Orlando, Florida, United States
A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease
- First Posted Date
- 2018-07-10
- Last Posted Date
- 2024-07-23
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 74
- Registration Number
- NCT03582137
- Locations
- 🇺🇸
University of Colorado hospital, Aurora, Colorado, United States
Shifting Brain Excitation-Inhibition Balance in Autism Spectrum Disorder
- First Posted Date
- 2018-05-25
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- King's College London
- Target Recruit Count
- 38
- Registration Number
- NCT03537950
- Locations
- 🇬🇧
King's College London, London, United Kingdom
Cannabidiol and Prolonged Exposure
- Conditions
- Interventions
- First Posted Date
- 2018-05-08
- Last Posted Date
- 2024-10-07
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 136
- Registration Number
- NCT03518801
- Locations
- 🇺🇸
VA San Diego Healthcare System, San Diego, CA, San Diego, California, United States
Cannabidiol - an in Vivo Innovative Drug Delivery Study
- First Posted Date
- 2018-03-20
- Last Posted Date
- 2020-07-01
- Lead Sponsor
- Central Institute of Mental Health, Mannheim
- Target Recruit Count
- 8
- Registration Number
- NCT03471559
- Locations
- 🇩🇪
Department I of Pharmacology, University of Cologne, Cologne, Germany
Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease
- Conditions
- Interventions
- First Posted Date
- 2018-03-16
- Last Posted Date
- 2020-03-25
- Lead Sponsor
- University of Illinois at Chicago
- Registration Number
- NCT03467620
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.